Financhill
Back

Evolus Quote, Financials, Valuation and Earnings

Evolus Price Quote

$12.73
+0.10 (+0.79%)
(Updated: November 21, 2024 at 9:35 AM ET)

Evolus Key Stats

Sell
32
Evolus (EOLS) is a Sell

Day range:
$12.17 - $12.65
52-week range:
$9.24 - $17.82
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.92
P/B ratio:
128.9%

Volume:
370K
Avg. volume:
642.1K
1-year change:
28.35%
Market cap:
$759.2M
Revenue:
$202.1M
EPS:
$-0.9

How Much Does Evolus Make?

  • How Much Are Evolus's Sales Annually?
    EOLS Revenues are $202.1M
  • How Much Profit Does Evolus's Make A Year?
    EOLS net income is -$61.7M

Is Evolus Growing As A Company?

  • What Is Evolus's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.22%
  • What Is Evolus's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Evolus Stock Price Performance

  • Did Evolus Stock Go Up Last Month?
    Evolus share price went down by -24.01% last month
  • Did EOLS's Share Price Rise Over The Last Year?
    EOLS share price rose by 28.35% over the past 1 year

What Is Evolus 52-Week High & Low?

  • What Is Evolus’s 52-Week High Share Price?
    Evolus has traded as high as $17.82 over the past 52 weeks
  • What Is Evolus’s 52-Week Low Share Price?
    Evolus has traded as low as $9.24 over the past 52 weeks

Evolus Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Evolus?

  • How Much Debt Does Evolus Have?
    Total long term debt quarterly is $121.2M
  • How Much Cash Does Evolus Have?
    Cash and short term investments quarterly total is $85M
  • What Is Evolus’s Book Value Per Share?
    Book value per share is 0.09

Is Evolus Cash Flow Positive?

  • What Is EOLS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$22M
  • What Is Evolus’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $72.2M
  • What Is Evolus’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$3.8M

Evolus Return On Invested Capital

  • Is Management Doing A Good Job?
    EOLS return on invested capital is -47.66%
  • What Is Evolus Return On Assets?
    ROA measures how assets are converting to revenues and is -26.5%
  • What Is EOLS Return On Equity?
    ROE is a measure of profitability and is -7724.23%

Evolus Earnings Date & Stock Price

  • What Is Evolus's Stock Price Today?
    A single share of EOLS can be purchased today for 12.63
  • What Is Evolus’s Stock Symbol?
    Evolus trades on the nasdaq under the ticker symbol: EOLS
  • When Is Evolus’s Next Earnings Date?
    The next quarterly earnings date for Evolus is scheduled on March 7, 2025
  • When Is EOLS's next ex-dividend date?
    Evolus's next ex-dividend date is November 21, 2024
  • How To Buy Evolus Stock?
    You can buy Evolus shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Evolus Competitors

  • Who Are Evolus's Competitors?
    Below is a list of companies who compete with Evolus or are related in some way:
    • Perspective Therapeutics Inc (CATX)
    • Electromed Inc (ELMD)
    • Myomo Inc (MYO)
    • Insulet Corp (PODD)
    • Xtant Medical Holdings Inc (XTNT)

Evolus Dividend Yield

  • What Is EOLS Dividend Yield?
    Evolus’s dividend yield currently is 0%
  • What Is Evolus’s Payout Ratio?
    Evolus’s payout ratio is 0%
  • When Did Evolus Last Pay A Dividend?
    The latest dividend pay date is November 21, 2024
  • What Is Evolus’s Dividend Per Share?
    Evolus pays a dividend of $0.00 per share

Evolus Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -66.67%
Revenue: 22.12% -3.66%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 23.43
Upside from Last Price: 85.5%

Major Shareholders

  • How many EOLS shares are owned by institutional investors?
    70.7M EOLS shares are owned by institutional investors
  • How many EOLS shares are owned by insiders?
    2.3M EOLS shares are owned by insiders